[{"AccountsPayableCurrent_0_Q3_USD":723300.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":496600.0,"OtherAssetsNoncurrent_0_Q3_USD":318100.0,"OtherAssetsCurrent_0_Q3_USD":3541900.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":1025100.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":500200.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":572300.0,"OperatingLeaseLiability_0_Q3_USD":1076700.0,"OperatingLeaseLeaseIncome_1_Q3_USD":4530400.0,"OperatingLeaseLeaseIncome_3_Q3_USD":9676100.0,"OperatingLeaseCost_3_Q3_USD":521100.0,"OperatingLeaseCost_1_Q3_USD":174200.0,"OperatingIncomeLoss_3_Q3_USD":-13233400.0,"OperatingIncomeLoss_1_Q3_USD":-2442900.0,"OperatingExpenses_3_Q3_USD":34554000.0,"OperatingExpenses_1_Q3_USD":11638200.0,"NetIncomeLoss_3_Q3_USD":-14207800.0,"NetIncomeLoss_1_Q3_USD":-2680400.0,"InvestmentIncomeInterest_3_Q3_USD":70000.0,"LeaseCost_1_Q3_USD":270800.0,"LeaseCost_3_Q3_USD":841600.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":1170300.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":579200.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":405000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-237500.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":186100.0,"Liabilities_0_Q3_USD":13574000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":277689900.0,"LiabilitiesCurrent_0_Q3_USD":12577200.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":233512800.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-183575150.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-9719350.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":93600.0,"InvestmentIncomeInterest_1_Q3_USD":51500.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-974400.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":2712050.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":87178217.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":84706516.0,"VariableLeaseCost_3_Q3_USD":226800.0,"VariableLeaseCost_1_Q3_USD":75600.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":334700.0,"StockIssuedDuringPeriodValueNewIssues_1_Q3_USD":184268400.0,"StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_1_Q3_USD":1086600.0,"StockholdersEquity_0_Q3_USD":264115900.0,"ShortTermLeaseCost_3_Q3_USD":31100.0,"ShortTermLeaseCost_1_Q3_USD":12200.0,"ShortTermInvestments_0_Q3_USD":196914700.0,"ShareBasedCompensation_3_Q3_USD":5510400.0,"SellingAndMarketingExpense_3_Q3_USD":8913500.0,"SellingAndMarketingExpense_1_Q3_USD":3211500.0,"Revenues_1_Q3_USD":10139100.0,"Revenues_3_Q3_USD":23742100.0,"RevenueRemainingPerformanceObligation_0_Q3_USD":1229400.0,"PaymentsToAcquireShortTermInvestments_3_Q3_USD":202867700.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":236077300.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_3_Q3_USD":22000000.0,"ProceedsFromSaleOfPropertyPlantAndEquipment_3_Q3_USD":4600.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":2424000.0,"ProfitLoss_3_Q3_USD":-14207800.0,"PaymentsOfStockIssuanceCosts_1_Q3_USD":17600000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":6810100.0,"RepaymentsOfNotesPayable_3_Q3_USD":4922400.0,"ResearchAndDevelopmentExpense_1_Q3_USD":2774800.0,"ResearchAndDevelopmentExpense_3_Q3_USD":12058000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-109430100.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":5608700.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":14066000.0,"PropertyPlantAndEquipmentTransfersAndChanges_3_Q3_USD":467600.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":84706516.0,"InventoryWriteDown_3_Q3_USD":0.0,"InventoryNet_0_Q3_USD":4148400.0,"CostOfRevenue_1_Q3_USD":943800.0,"ContractWithCustomerLiabilityRevenueRecognized_3_Q3_USD":4400000.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q3_USD":2600000.0,"ContractWithCustomerLiability_0_Q3_USD":6800000.0,"CommonStockValue_0_Q3_USD":1004300.0,"CommonStockSharesOutstanding_0_Q3_shares":100434032.0,"CommonStockSharesIssued_0_Q3_shares":100434032.0,"CommonStockSharesAuthorized_0_Q3_shares":200000000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.01,"CommitmentsAndContingencies_0_Q3_USD":null,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":40218300.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":58973500.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":58973500.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":153950.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":253625500.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":253563100.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":800.0,"AccountsReceivableNetCurrent_0_Q3_USD":5958100.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":39500.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q3_USD":4955800.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":3960500.0,"AdditionalPaidInCapital_0_Q3_USD":372541700.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":2285400.0,"CostOfRevenue_3_Q3_USD":2421500.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":2285400.0,"AllowanceForDoubtfulAccountsReceivable_0_Q3_USD":0.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":13000000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":13000000.0,"Assets_0_Q3_USD":277689900.0,"AssetsCurrent_0_Q3_USD":269536600.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":63200.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":5510400.0,"InventoryRawMaterials_0_Q3_USD":1615700.0,"DeferredCosts_0_Q3_USD":0.0,"DepreciationAndAmortization_1_Q3_USD":366000.0,"InventoryFinishedGoods_0_Q3_USD":2532700.0,"InterestPaidNet_3_Q3_USD":420900.0,"InterestExpense_3_Q3_USD":5400.0,"InterestCostsCapitalized_1_Q3_USD":0.0,"InterestCostsCapitalized_3_Q3_USD":0.0,"IncreaseDecreaseInOtherOperatingLiabilities_3_Q3_USD":-27100.0,"IncreaseDecreaseInOtherNoncurrentAssets_3_Q3_USD":284200.0,"IncreaseDecreaseInOtherCurrentAssets_3_Q3_USD":2538900.0,"IncreaseDecreaseInOperatingLeaseLiability_3_Q3_USD":-734700.0,"IncreaseDecreaseInInventories_3_Q3_USD":300200.0,"IncreaseDecreaseInDeferredRevenue_3_Q3_USD":1482800.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":786200.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_3_Q3_USD":-431350.0,"GrossProfit_3_Q3_USD":21320600.0,"GrossProfit_1_Q3_USD":9195300.0,"GeneralAndAdministrativeExpense_3_Q3_USD":13582500.0,"GeneralAndAdministrativeExpense_1_Q3_USD":5651900.0,"DepreciationAndAmortization_3_Q3_USD":1007400.0,"EarningsPerShareBasic_1_Q3_USD":-0.03,"EarningsPerShareBasic_3_Q3_USD":-0.16,"EarningsPerShareDiluted_1_Q3_USD":-0.03,"EarningsPerShareDiluted_3_Q3_USD":-0.16,"FairValueAdjustmentOfWarrants_3_Q3_USD":645400.0,"DeferredRevenueCurrent_0_Q3_USD":6325800.0,"FinanceLeaseInterestExpense_1_Q3_USD":900.0,"FinanceLeasePrincipalPayments_3_Q3_USD":66100.0,"FinanceLeaseRightOfUseAssetAmortization_1_Q3_USD":7900.0,"FinanceLeaseRightOfUseAssetAmortization_3_Q3_USD":55600.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q3_USD":26200.0,"ForeignCurrencyTransactionGainLossBeforeTax_3_Q3_USD":49600.0,"GainLossOnSaleOfPropertyPlantEquipment_3_Q3_USD":-18500.0,"FinanceLeaseInterestExpense_3_Q3_USD":7000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":87178217.0,"Ticker":"MXCT","CIK":"1287098","name":"MAXCYTE, INC.","OfficialName":"MaxCyte Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"544088771.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20211110"}]